If you have kidney disease, your doctor will likely start you on a lower dose and monitor you closely
According to a report from the health policy research organization KFF released in November, half of the remaining state Medicaid programs are considering covering the drugs, but the high costs are still prohibitive for most despite federal matches and rebate programs with drug manufacturers
Mirzaei M, Bouyeh M, Zahedi A, Seidavi A, Khan RU, Tufarelli V, Laudadio V, Abd El-Hack ME, Ragni M, Taha AE, Swelum AA
Per molti pazienti questo diventa una routine mattutina (sveglia, pillola, doccia, colazione)
This has some important implications
And since these are the diseases that shorten human life GLP1s can reasonably be assumed to be medications that will extend lifespan/healthspan